Literature DB >> 17079099

Transient hypothyroxinaemia in preterm infants.

Fiona L R Williams1, Theo J Visser, Robert Hume.   

Abstract

Thyroid hormones are required for normal development of the brain. Transient hypothyroxinaemia is the most common thyroid dysfunction in preterm infants and is defined by temporary low levels of T4, T3 and normal or low TSH. Low T4 levels in preterm infants are associated with persistent neurodevelopmental deficits in cognitive and motor function. Thyroid hormone substitution trials to date are underpowered and show inconsistent results; the question remains -- are low T4 levels simply an epiphenomenon? The aetiology of transient hypothyroxinaemia is multifactorial and the components amenable to correction form the basis of the therapeutic strategy: rectification of iodine deficiency in parenteral nutrition; a reduction of non-thyroidal illnesses and attenuation of their severity; and substitution of drugs that interfere with the hypothalamic-pituitary-thyroid axis. Thyroxine substitution therapy should only be done in the context of clinical trials and only in those infants who are hypothyroxinaemic.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079099     DOI: 10.1016/j.earlhumdev.2006.09.007

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  10 in total

1.  Gestational Hypothyroxinemia Affects Glutamatergic Synaptic Protein Distribution and Neuronal Plasticity Through Neuron-Astrocyte Interplay.

Authors:  Pablo Cisternas; Antoine Louveau; Susan M Bueno; Alexis M Kalergis; Hélène Boudin; Claudia A Riedel
Journal:  Mol Neurobiol       Date:  2015-12-19       Impact factor: 5.590

2.  Follow-up study of preterm infants with thyroid dysfunction after medication.

Authors:  Feng-Chao Li; Jian-Ying Duan; Yin-Hong Zhang; Si-Qi Han; Xiao-Lin Ma; Shi-Yan Cai; Li Li
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2021-12-15

3.  Effect of levothyroxine supplementation in extremely low birth weight infants with transient hypothyroxinemia of prematurity.

Authors:  Shin Ae Yoon; Yun Sil Chang; Misun Yang; So Yoon Ahn; Se In Sung; Hee-Seung Cho; Won Soon Park
Journal:  Sci Rep       Date:  2022-06-11       Impact factor: 4.996

4.  Are preterm newborns who have relative hyperthyrotropinemia at increased risk of brain damage?

Authors:  Steven J Korzeniewski; Carmen L Soto-Rivera; Raina N Fichorova; Elizabeth N Allred; Karl C K Kuban; T Michael O'Shea; Nigel Paneth; Michael Agus; Olaf Dammann; Alan Leviton
Journal:  J Pediatr Endocrinol Metab       Date:  2014-11       Impact factor: 1.634

5.  Thyroxine Threshold Is Linked to Impaired Outcomes in Preterm Infants.

Authors:  Stephanie Coquelet; Helene Deforge; Jean-Michel Hascoët
Journal:  Front Pediatr       Date:  2020-05-05       Impact factor: 3.418

6.  Neurodevelopmental Outcomes at 42 Months After Thyroxine Supplementation in Infants Below 28 Weeks' Gestation: A Randomized Controlled Trial.

Authors:  Sze May Ng; Mark A Turner; A Michael Weindling
Journal:  Thyroid       Date:  2020-03-17       Impact factor: 6.568

7.  Initial and delayed thyroid-stimulating hormone elevation in extremely low-birth-weight infants.

Authors:  Shin Ae Yoon; Yun Sil Chang; So Yoon Ahn; Se In Sung; Won Soon Park
Journal:  BMC Pediatr       Date:  2019-10-11       Impact factor: 2.125

8.  TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation.

Authors:  Sze M Ng; Mark A Turner; Carrol Gamble; Mohammed Didi; Suresh Victor; Alan M Weindling
Journal:  Trials       Date:  2008-03-26       Impact factor: 2.279

9.  An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks' gestation: results of the TIPIT trial.

Authors:  Sze M Ng; Mark A Turner; Carrol Gamble; Mohammed Didi; Suresh Victor; Donal Manning; Paul Settle; Richa Gupta; Paul Newland; Alan Michael Weindling
Journal:  Trials       Date:  2013-07-11       Impact factor: 2.279

10.  Thyroid function and dysfunction in term and premature equine neonates.

Authors:  B A Breuhaus
Journal:  J Vet Intern Med       Date:  2014-06-16       Impact factor: 3.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.